Psychotropic drug use among persons with mental distress symptoms: A population-based study in Norway

Scandinavian Journal of Public Health

Volumn 35, Issue 4, 2007, Pages 356-364

  Hausken, Anne M ^a   Skurtveit, Svetlana ^a   Bramness, Jørgen G ^a   Furu, Kari ^a   Rosvold, Elin O ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Analgesics; antidepressants; anxiolytics; employment status; hypnotics; mental distress symptoms; population based; psychotropic drugs

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; SOCIOECONOMICS;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LIFE STYLE; MALE; MENTAL DISORDERS; MIDDLE AGED; NORWAY; PREVALENCE; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 34548585346     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940601159161     Document Type: Article

References (30)

1. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., et al. Psychotropic drug utilization in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004;(Suppl):55-64.
2. Rønning M, editor. Drug consumption in Norway 2000— 2004. [Legemiddelforbruket i Norge 2000—2004: en statistisk fremstilling av legemiddelforbruket i Norge for årene 2000—2004 basert på omsetning av legemidler fra legemiddelgrossister til apotek, sykehus og dagligvarehandel] Oslo: Norwegian Institute of Public Health; 2005.
3. Rønning M. Coding and classification in drug statistics: From national to global application. Nor J Epidemiology 2001;11:37-40.
4. Health Statistics in the Nordic Countries 2001 [Helsestatistik for de nordiske lande 2001]. 66:2003. København, Nordic Medico Statistical Committee (NOMESCO); 2003.
5. Bramness J.G., Hausken A.M., Sakshaug S., Skurtveit S., Ronning M. Prescription of selective serotonin reuptake inhibitors 1990—2004. [Forskrivning av selektive serotoninreopptakshemmere 1990—2004] Tidsskr Nor Laegeforen 2005; 125:2470-3.
6. Pallesen S., Nordhus I.H., Nielsen G.H., Havik O.E., Kvale G., Johnsen B.H., Skjotskift S. Prevalence of insomnia in the adult Norwegian population. Sleep 2001;24:771-9.
7. Bjorndal A., Forsén L. En pille for alt som er ille? En analyse av psykofarmakaforbruket i Helseundersøkelsen i Nord-Trøndelag 1984—86 (English summary). Report no. 7. Oslo: Unit for Health Services Research, National Institute of Public Health; 1989.
8. Nielsen M.W., Hansen E.H., Rasmussen N.K. Patterns of psychotropic medicine use and related diseases across educational groups: National cross-sectional survey. Eur J Clin Pharmacol 2004;60:199-204.
9. Empereur F., Baumann M., Alla F., Briancon S. Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over. J Clin Pharm Ther 2003;28:61-68.
10. Ohayon M.M., Lader M.H. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002;63:817-825.
11. Villaverde Ruiz ML, De la Fuente JA, Gracia M.R., Agullar Garcia-Iturrospe E. Psychotropic and analgesic drugs consumption in general population in Tenerife Island. Eur J Psychiatry 2000;14:213-220.
12. Blennow G., Romelsjo A., LeifmanH., LeifmanA., KarlssonG. Sedatives and hypnotics in Stockholm: Social factors and kinds of use. Am J Public Health 1994;84:242-6.
13. Isacson D., Haglund B. Psychotropic drug use in a Swedish community: The importance of demographic and socioeconomic factors. Soc Sci Med 1988; 26:477-483.
14. Tellnes G., Bjorndal A., Fugelli P. Psychotropic drug-users and non-users in general practice, I: A three-year retrospective study from an island community in northern Norway. Scand J Prim Health Care 1986;4:131-5.
15. Grohmann R., Engel R.R., Geissler K.H., Ruther E. Psychotropic drug use in psychiatric inpatients: Recent trends and changes over time — data from the AMSP study. Pharmacopsychiatry 2004;37(Suppl 1):S27-S38.
16. Voirol P., Robert P.A., Meister P., Oros L., Baumann P. Psychotropic drug prescription in a psychiatric university hospital. Pharmacopsychiatry 1999; 32:29-37.
17. Marino S. Ill-health and social predictors of psychotropic drug prescription in general practice. Int J Soc Psychiatry 1993;39:167-176.
18. Rundberg J., Lidfeldt J., Nerbrand C., Samsioe G., Romelsjo A., Ojehagen A. Few middle-aged women with severe mental symptoms use psychotropic drugs: The Women's Health in Lund Area (WHILA) study. Scand J Public Health 2005;33:384-391.
19. Strand B.H., Dalgard O.S., Tambs K., Rognerud M. Measuring the mental health status of the Norwegian population: A comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry 2003;57:113-118.
20. Selmer R., Soegard A.J., Bjertness E., Thelle D. The Oslo Health Study: Reminding the non-responders — effects on prevalence estimates. Nor J Epidemiol 2003;13:89-94.
21. The Oslo Health Study. Main questionnaire. Available at http://www.fhi.no/dav/66091FDE33734FAB96849B26D9-F46333.pdf (accessed 17 January 2006).
22. Furu K., Skurtveit S., Rosvold E. Drug use questions in Norwegian health surveys: Response rate and agreement between specific and open-ended questions. Nor J Epidemiol 2003;13:147-154.
23. Derogatis L.R., Lipman R.S., Rickels K., Uhlenhuth E.H., Covi L. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 1974;19:1-15.
24. Hartikainen S., Mantyselka P., Louhivuori-Laako K., Enlund H., Sulkava R. Concomitant use of analgesics and psychotropics in home-dwelling elderly people — Kuopio 75+study. Br J Clin Pharmacol 2005; 60:306-310.
25. Zimmermann-Tansella C., Donini S., Ciommei A.M., Siciliani O. Social factors associated with the use of psychotropic drugs: Alcohol abuse and minor psychiatric morbidity in the community. Acta Psychiatr Scand 1988;1:14-21.
26. Van Dongen CJ Quality of life and self-esteem in working and nonworking persons with mental illness. Community Ment Health J 1996;32:535-548.
27. Miguel R.V. Pain medicine: Why and when to call for the addictionologist and/or psychiatrist. Regional Anesthesia & Pain Management, 2005:221-7.
28. Power J.D., Perruccio A.V., Badley E.M. Stress, depression and pain as mediators between chronic conditions and sleep problems. Am J Epidemiol 2005;161:S6.
29. Søgaard A., Selmer R., Bjertness E., Thelle D. The Oslo Health Study: The impact of self-selection in a large, population-based survey. Int J Equity Health 2004;3:3.
30. Van den Brandt P.A., Petri H., Dorant E., Goldbohm R.A., Van de C.S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 1991;13:91-96.